COMMUNIQUÉS West-GlobeNewswire

-
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2025
12/06/2025 -
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
12/06/2025 -
Syndax Announces Publication of Revumenib Data from the BEAT AML Trial in the Journal of Clinical Oncology and Simultaneous Presentation at EHA 2025
12/06/2025 -
Major shareholder announcement
12/06/2025 -
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
12/06/2025 -
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
12/06/2025 -
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
12/06/2025 -
I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/06/2025 -
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
12/06/2025 -
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
12/06/2025 -
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
12/06/2025 -
Counslr Launches in Texas to Increase Access to Mental Health Support for Staff and Students
12/06/2025 -
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
12/06/2025 -
Spring Bio Solution lance NCE Grid pour décoder les dépôts Para IV et les opportunités de premier déposant
12/06/2025 -
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
12/06/2025 -
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
12/06/2025 -
NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market
12/06/2025 -
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
12/06/2025 -
Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
12/06/2025
Pages